22 Presentations Highlight Advances in Dermatology
SYDNEY — Galderma has announced its participation in the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, showcasing its latest dermatology solutions. Over 22 presentations will be made, covering Therapeutic Dermatology, Injectable Aesthetics, and Dermatological Skincare.
According to Galderma, the event will feature data on Nemluvio for atopic dermatitis and new insights into its hyaluronic acid injectables, Restylane, and neuromodulator RelabotulinumtoxinA. The company aims to underline its commitment to scientific excellence and patient care.
Comprehensive Dermatology Solutions
Dr. Baldo Scassellati Sforzolini, Global Head of R&D, stated, “The range of data we are presenting at AAD shows the strength of our commitment to this across every part of our portfolio.” This includes the use of artificial intelligence to identify sensitive skin factors and studies on the Cetaphil range for various skin types.
The announcement comes as dermatology continues to see growing demand for innovative solutions. Galderma’s participation in AAD 2026 highlights its ongoing efforts to meet diverse patient needs worldwide.
In addition to showcasing its latest products, Galderma will also engage with leading dermatologists and researchers to foster collaborations and explore new avenues in dermatological research. The company’s focus on collaboration underscores its belief that partnerships are key to advancing dermatological science. Galderma’s suite of presentations will also include discussions on the impact of climate change on skin health and how emerging technologies can be leveraged to provide better skincare solutions.
As the global dermatology landscape evolves, Galderma remains dedicated to addressing the challenges faced by patients and healthcare providers. By investing in research and development, the company is poised to deliver cutting-edge solutions that enhance patient outcomes. The AAD 2026 meeting serves as a platform for Galderma to demonstrate its leadership in the dermatology field and to share its vision for the future of skincare.
Source: newshub.medianet.com.au
Last updated: 29 June 2026, 12:43 pm
